Evan J. Lipson
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways
Most-Cited Works
- → Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies(2014)5,004 cited
- → Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab(2014)2,197 cited
- → PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma(2016)1,234 cited
- → Evolutionary dynamics of cancer in response to targeted combination therapy(2013)641 cited
- → Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors(2016)626 cited
- → Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma(2011)552 cited
- → Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody(2012)540 cited
- → Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy(2016)506 cited
- → Cardiovascular toxicities associated with immune checkpoint inhibitors(2019)487 cited
- → Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer(2013)421 cited